This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
VIA AILooking for an interpreter?
Remoto by ProZ.com connects you with an identity-verified interpreter by video or phone in about 60 seconds — 300+ languages, on demand or booked ahead.
Try Remoto »
Idiomas de trabajo:
inglés al español español al inglés
Client-vendor relationship recorded successfully!
María Agustina Limia has been added to your list of hired vendors.
María Agustina Limia
4 years of experience in translating
Argentina
Hora local: 15:18 -03 (GMT-3)
Idioma materno: español (Variants: Latin American, Argentine)
This person is not affiliated with any business or Blue Board record at ProZ.com.
Servicios
Linguistic validation, Translation, Subtitling, Project management, Editing/proofreading, AI + Human review (MT post-editing), Terminology management
Especialización
Se especializa en
Medicina: Salud
Medicina (general)
Medicina: Farmacia
Biología (biotecnología/química, microbiología)
Nutrición
Agricultura
Lingüística
Psicología
Viajes y turismo
También trabaja en
Derecho: (general)
Alimentos y bebidas
More
Less
Tarifas
General rate: 0.67 USD per word / 12 USD per hour
Payment methods accepted
Visa
Muestrario
Muestras de traducción: 1
inglés al español: Clinical Trial General field: Medicina Detailed field: Medicina: Salud
Texto de origen - inglés Abstract
Background: The immunotherapeutic vaccine Interferon-kinoid (IFN-K) consists of a heterocomplex of inactivated recombinant human IFN-2b coupled to a T-helper carrier protein, Keyhole Limpet Haemocyanin. A phase 1/ll was published. Here, we report the results of a 36 week, phase 2b, randomized, double-blind, placebo-controlled, multi-center study assessing the efficacy and safety of IFN-K in patients with active systemic lupus erythematosus (SLE) on standard of care therapy.
Traducción - español Resumen
Antecedentes: la vacuna inmunoterapéutica Interferón-kinoid (IFN-K) está compuesta por un heterocomplejo de IFN-2b recombinante humano inactivado y acoplado a una proteína transportadora de linfocitos T colaboradores, la hemocianina de lapa californiana. Se publicó un ensayo de fase I/II, en el cual demostramos los resultados de un estudio en fase 2b, aleatorizado, controlado con placebo, con doble enmascaramiento, multicéntrico, de 36 semanas de duración, y en el que se evalúa la eficacia y seguridad del IFN-K en pacientes con lupus eritematoso sistémico activo (LES) con tratamiento de preferencia.
More
Less
Formación en el ámbito de la traducción
Bachelor's degree - ISPI N 4011
Experiencia
Años de experiencia: 4 Registrado en ProZ.com: Dec 2024
Adobe Acrobat, Adobe Illustrator, Adobe Photoshop, Aegisub, CaptionHub, MateCat, Microsoft 365, Microsoft Excel, Microsoft Word, OmegaT, Powerpoint, ProZ.com Translation Center, Trados Online Editor, Trados Studio
Bio
I provide professional English–Spanish language solutions and can help you with:
• Translation and localisation
• Subtitling
• Proofreading and editing
• Machine Translation Post-Editing (MTPE)
My fields of expertise are:
✅ Medical & Healthcare: medical content, healthcare communication, patient-facing materials, and medical terminology
✅ Pharmaceutical: pharmaceutical documentation
✅ Legal: legal documents and institutional communication
✅ Tourism: tourism-related content and travel communication
If you have any questions or would like to discuss working together, feel free to contact me.
📩 [email protected]
Especialización